an oral therapy for the treatment of non-proliferative diabetic retinopathy (NPDR). Diabetic retinopathy affects more than 100 million people worldwide and is one of the leading causes of ...

an oral therapy for the treatment of non-proliferative diabetic retinopathy (NPDR). Diabetic retinopathy affects more than 100 million people worldwide and is one of the leading causes of blindness ...

Peter Svaldi is taking the company to court, citing poor living conditions. “In my experience, it was very traumatic and impactful to my life,” he said. Svaldi said he experienced several ...

Vantage Biosciences has successfully dosed the first patient in its phase 2 clinical study evaluating VX-01, an oral therapy for the treatment of nonproliferative diabetic retinopathy (NPDR).

Background: Diabetic retinopathy, a major microvascular complication of diabetes, significantly contributes to global blindness. Emerging evidence suggests a potential association between depression ...

MILFORD, Conn. (WFSB) - A stray tire that slammed a car on the highway caused “traumatic” injuries to a woman on Tuesday morning. According to the Milford Fire Department, at around 8:28 a.m ...

MCCRACKEN COUNTY — As people begin to recover from flooding, it can sometimes be difficult to determine which organization can best serve them. People in one flooded community shared their ...

Fasting C-peptide (FCP) shows a nonlinear relationship with diabetic retinopathy (DR) risk, with a protective effect below 4.11 ng/mL. Above 4.11 ng/mL, the protective effect of FCP on DR becomes ...